Introduction
Atherosclerosis is now generally accepted to be an inflammatory disorder in the arterial wall (1) . Japan has a relatively high prevalence of Helicobacter pylori among developed countries (2) . It has been hypothesized that exposure to this agent promotes the initiation and progression of atherosclerosis. Seropositivity to H. pylori has been postulated to be a risk factor for cardiovascular and cerebrovascular disease (CVD) (3, 4) . From an epidemiological perspective, however, the role of H. pylori in the pathogenesis of coronary artery disease remains controversial, and a recent meta-analysis revealed only limited evidence of a positive relationship (5) .
Pulse wave velocity (PWV) is known to be an indicator of arterial stiffness (6, 7) , and there have been many reports on PWV and the development of atherosclerotic disease (8−10) . A simple method for noninvasive automatic measurement of brachial-ankle PWV (baPWV) has recently been developed. The technical simplicity and short sampling time of the new method make it more feasible for screening a large population than previous methods, such as carotid-femoral PWV. However, the relation of H. pylori infection to arterial stiffness as a marker of early stage atherosclerosis has not been fully investigated. In this study, we investigated the influence of H. pylori infection on arterial stiffness to clarify whether H. pylori infection is related to early stage atherosclerosis.
Methods

Subjects
The subjects were local government employees (8,229 men and 2,194 women) aged 35 years or more who had their annual health checkup during the period from April 2003 through March 2004. We used a self-administered questionnaire including items on clinical history, family history, smoking, alcohol consumption, educational status, frequency of exercise, menopausal status, and hormone-replacement therapy. The questionnaires were distributed to the subjects in advance of their annual health checkup, and were collected at the checkup. Answers to the questionnaire and written consent to view health checkup data were obtained from 3,907 men and 1,044 women (response rate: men 47.5%, women 47.6%). A total of 685 subjects (495 men, 190 women) were excluded for the following reasons: past history of coronary disease or stroke (n= 136; 124 men, 12 women), low ankle/ Variables are presented as mean±SD, median (interquartile range) for skewed variables, or percentage. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high density lipoprotein cholesterol; CRP, C-reactive protein; PWV, pulse wave velocity.
brachial pressure index (< 0.9, n= 12; 11 men, 1 woman), PWV not measured (n= 600; 416 men, 184 women), or blood samples not measured (n= 3; 3 women). The final study group thus consisted of 3,412 male and 854 female subjects. This study was conducted with all the subjects' written informed consent and approved by the institutional ethical board for epidemiological studies of Hokkaido University Graduate School of Medicine.
Data Collection
Smoking habits were classified as never, ex-smoker, 1−19 cigarettes per day or ≥ 20 cigarettes per day for men; and never, ex-smoker or current smoker for women. The total average amount of alcohol consumed was calculated in g per day, after taking into account the frequency, amount, and alcohol content for specific beverages. Alcohol consumption was categorized into rarely or never, ≤ 19.9 g/day, 20−39.9 g/ day, 40−59.9 g/day or ≥ 60 g/day for men; and rarely or never, ≤ 19.9 g/day or ≥ 20 g/day for women. The frequency of leisure time exercise (with perspiration) was categorized into rarely or never, 1−2 per week or ≥ 3 per week. Educational attainment was categorized into high school education or less or more than high school education. Women who reported ). Blood samples were drawn from the antecubital vein of the seated subject with minimal tourniquet use after a 12-h fast. Specimens were collected in siliconized glass vacuum tubes containing sodium fluoride for blood glucose, and no additives for serum.
Total cholesterol (TC) levels were measured by an enzymatic method (Wako, Osaka, Japan). Triglyceride (TG) levels were measured by an enzymatic method (Daiichi Pure Chemicals, Tokyo, Japan), high density lipoprotein cholesterol (HDL-C) levels by a direct method (Daiichi Pure Chemicals), blood glucose levels by an amperometric method (ARKRAY, Kyoto, Japan), and uric acid (UA) by an enzymatic method (Daiichi Pure Chemicals).
C-reactive protein (CRP) levels were measured by nephelometry, a latex particle-enhanced immunoassay (N Latex CRP II; Dade Behring, Tokyo, Japan). The assay could detect 0.004 mg/dl of CRP. Undetectable CRP values were recorded as 0.002 mg/dl. Serum concentrations were dichotomized with the gender-segregated median values (0.045 mg/dl for males and 0.025 mg/dl for females) as the cutoff point. Concentrations > 0.045 mg/dl for males and > 0.025 mg/dl for females were defined as high CRP, and others were defined as low CRP.
The anti-H. pylori antibody concentration was measured using an enzyme immunoassay (E plate; Eiken Chemical, Tokyo, Japan) (11); an assay value < 10 U/ml was considered negative, and a value ≥ 10 U/ml was considered positive.
All blood variables except for CRP and the anti-H. pylori antibody were measured at Daiichi Clinical Laboratories, Inc. (Sapporo, Japan), a commercial hematology laboratory, where the measurements of TC and HDL cholesterol were all standardized by the Lipid Standardized Program of the Centers for Disease Control and Prevention (Atlanta, USA). CRP and the anti-H. pylori antibody were measured at Mitsubishi Kagaku Bio-Clinical Laboratories, Inc. (Tokyo, Japan), a commercial hematology laboratory.
baPWV was measured using a volume-plethysmographic apparatus (Form PWV/AVI; model BP-203RPEII, Colin Co., Komaki, Japan) (12−14) . This device records the phonocardiogram, electrocardiogram, and volume pulse form and arterial blood pressure at both the left and right brachia and ankles. baPWV was calculated by time-phase analysis between the right brachial and volume waveforms at both ankles. The distance between the right brachium and ankle was estimated based on body height. Yamashina et al. reported that baPWV was significantly correlated with arterial PWV measured directly by a catheter pressure transducer (n= 41, r= 0.87, p< 0.01), and that the coefficients of variation of interobserver and intraobserver reproducibility were 8.4% and 10.0%, respectively (12) . Since there was a significant positive correlation between left and right baPWV (r= 0.95, p< 0.0001), we used a mean right and left baPWV value during analysis.
Blood pressure, heart rate (HR), and the ankle brachial index (ABI) were measured using the pulse-wave velocimeter at the same time that PWV was measured. ABI was the ratio of ankle systolic blood pressure (SBP) to brachial SBP, and the right and left ABIs were measured simultaneously. In all the studies, baPWV was obtained after an at least 5-min rest.
Statistical Analysis
All analyses were performed separately for men and women. The data of the subjects are presented as the mean ±SD, the median (and interquartile range) for variables with a skewed distribution, or percentages. Values in the two groups according to H. pylori serology were compared by the Student's unpaired t-test for variables with approximately normal distribution, by the Wilcoxon rank-sum test for variables with a skewed distribution, or by the χ 2 -test for categorical data. Next, study subjects were categorized according to tertiles of PWV values with the sexes separated. Analysis of variance (ANOVA), the Kruskal-Wallis test, or the χ 2 -test was used to compare data for these groups. Logistic regression analyses were used to evaluate whether H. pylori seropositivity and high CRP levels were predictors of high values of PWV (tertile three). As the next step, combined variables (H. pylori seronegative and low CRP, H. pylori seropositive or high CRP, H. pylori seropositive and high CRP) were created, and their association with a high value of PWV was evaluated. Odds ratios (OR) and 95% confidence intervals (CI) were calculated before and after adjustment for potential confounders. The following potential confounders were included in the multivariate logistic regression models as independent variables: age, BMI, SBP, HR, TC, HDL-C, fasting glucose, log TG, UA, smoking status, alcohol consumption, frequency of exercise, educational attainment, medication for hypertension, medication for hyperlipidemia, and medication for diabetes for men; and all of these variables and menopausal status for women. p-values < 0.05 were considered to be statistically significant. All analyses were conducted using the SPSS software package Version 12 for Windows (SPSS Inc., Chicago, USA).
Results
Of the 3,312 male subjects, 1,586 (46.5%) had anti-H. pylori antibodies, and of the 854 female subjects, 358 (41.9%) had anti-H. pylori antibodies.
Characteristics of the groups according to H. pylori seropositivity are presented in Table 1 for males and Table 2 for females. In male subjects, the variables were significantly different between the H. pylori antibody seropositive and seronegative groups except for BMI, HR, UA, alcohol consumption, frequency of exercise, medication for hyperlipidemia, and medication for diabetes. In female subjects, the variables were significantly different between the H. pylori antibody seropositive and seronegative groups except for heart rate, CRP, smoking habit, frequency of exercise, medication for hypertension, medication for hyperlipidemia, medication for diabetes and current use of hormone-replacement therapy. In both genders, the mean PWV values were significantly higher in the H. pylori seropositive group than in the seronegative group.
Characteristics of the groups divided by PWV tertiles are shown in Table 3 for males and Table 4 for females. In male subjects, all variables except HDL-C were significantly different among the PWV tertiles. In female subjects, all variables except smoking habit, frequency of exercise, and Variables are presented as mean±SD, median (interquartile range) for skewed variables, or percentage. Abbreviations are the same as in Table 1 .
current use of hormone-replacement therapy were significantly different among the PWV tertiles. In both genders, there was a significant increase in prevalence of H. pylori seropositivity across the PWV categories.
In unadjusted logistic regression analysis of all male subjects ( We also categorized subjects into two age groups (≤ 49 and ≥ 50 years). In unadjusted logistic regression analyses of female subjects ≤ 49 years old, high CRP and a combination 
Discussion
In this study, H. pylori seropositivity and a combination of H. pylori seropositivity and high CRP were significantly associated with an increase of arterial stiffness in males even after controlling for known and potential cardiovascular risk factors, particularly in those less than 50 years old. Therefore, it is probable that inflammation following H. pylori infection contributes to the early stage of atherosclerosis in younger males. It has been postulated that seropositivity to H. pylori is a risk factor for cardiovascular and cerebrovascular disease (3, 4) . But a recent meta-analysis revealed only limited evidence of a positive relationship (5) . Meanwhile, in a case control study of a Japanese population, H. pylori seropositivity was significantly associated with acute myocardial infarction (AMI) in subjects < 55 years (OR 2.97), but was not associated with AMI for subjects aged ≥ 55 years (55−64 years: OR 1.03; > 65 years: OR 0.79) (15) . Another Japanese case-control study showed that H. pylori seropositivity was significantly associated with coronary heart disease (OR 1.34) (16) . It has been reported that genetic polymorphisms were related to H. pylori-associated gastric cancer or peptic ulcer (17, 18) . Thus, a racial difference in the susceptibility to atheroscle- Table 5. rotic diseases conferred by H. pylori infection might be present through racial-specific genetic characteristics. Furthermore, there were significant associations between H. pylori seropositivity and atherosclerosis in the younger subjects of our study and in the subjects of the former Japanese case-control study (16) . This is probably because the associations of most risk factors with CVD and coronary heart disease (CHD) tend to be stronger in younger than in older subjects (19, 20) . Adachi et al. reported that heart carotid PWV was higher in H. pylori seropositive than H. pylori seronegative young (< 39-year-old) subjects (21) . However, the sample size was rather small (683 males and 313 females) and the analysis was only adjusted by age, sex, BMI, smoking, and drinking habits; i.e., HR, blood pressure, TC, TG, HDL-C, and fasting glucose were not included in the model. Additionally, there was no data on the socioeconomic status of the subjects. Thus, the results were not adjusted for potential confounders.
The present study could not identify a causal role for H. pylori infection in the pathogenesis of arterial stiffness. However, it has been reported that H. pylori is detected not only in gastric mucosa but also in human atherosclerotic plaque (22, 23) , and the expression of intercellular adhesion molecule-1 is higher in plaques containing H. pylori than in those which do not (23) . H. pylori infection stimulates the production of proinflammatory cytokines such as tumor necrosis factor, interleukin-6, and interleukin-8 (24, 25) , and the association of H. pylori with elevations of serum CRP and fibrinogen has been reported (3, 26) . In this study, male subjects aged ≤ 49 years with both H. pylori seropositivity and high CRP had a relatively high OR (1.81). Therefore, it is considered that there is an effect on atherosclerosis when H. pylori infection induces its higher inflammatory response. Antioxidants have been shown to be decreased in subjects with H. pylori (27) . This could contribute to lipid peroxidation, which in turn could result in atherosclerosis (28) .
In contrast, in adjusted analyses of female subjects, neither H. pylori seropositivity nor the combination of H. pylori seropositivity and high CRP was associated with arterial stiffness. The smaller sample size (a quarter of that of male subjects) reduced the statistical power. Also, it is well known that menopause aggravates the progression of atherosclerosis (29) , and the CRP level of females is lower than that of males (30) . In another previous study, the baPWV of females was significantly lower than that of males in subjects ≤ 55 years old (13) , so H. pylori infection in younger females might have a limited effect on arterial stiffness.
A recent large study consisting of 5,732 Japanese showed that the overall prevalence of H. pylori seropositivity was 47.0% (31). The prevalence of H. pylori seropositivity in our male subjects resembled that of this previous report, but for females it was rather small, presumably because our female subjects were somewhat younger than our male subjects. Because this study examined IgG antibodies to H. pylori, which can reflect a previous infection, IgG seropositivity to H. pylori may not reflect active infection. But the relative sensitivity, specificity and rates of agreement between the results obtained using the enzyme immunoassay employed in the present study (E plate) and those obtained by the culture/rapid urease test have been reported to be 100%, 80.0%, and 97.1%, respectively (12) . Thus the serological method to detect H. pylori infection should be selected for screening a large population.
Socioeconomic status is known to affect both the prevalence of H. pylori infection and the risk of atherosclerosis (32) . We could not obtain the subjects' income data, but the subjects worked for one local government. We therefore believe that the subjects were socioeconomically similar, and our data were adjusted for educational attainment, so it was considered that the influence of socioeconomic status on the adjusted OR was practically nil.
The present study has several limitations. First, this study could not identify a causal role for H. pylori infection in the pathogenesis of arterial stiffness. Second, we measured only the seropositivity of H. pylori infection. However, as previously mentioned, we believe that the serological method to detect H. pylori infection is sufficient for a large population study. Third, we could not obtain information about incomes of the subjects. However, as previously mentioned, we considered that the influence of socioeconomic status on the adjusted OR was practically nil. Forth, statins lower the level of CRP (33, 34) . We knew whether the subjects were taking medication for hyperlipidemia or not, but we could not identify the name of their medications. Thus, the analyses were adjusted for medication for hyperlipidemia. Finally, the number of female subjects was rather small. A further study with a larger number of female subjects is thus required.
In summary, our results indicate that H. pylori seropositivity and H. pylori seropositivity with elevated CRP levels are significantly associated with an increase of arterial stiffness in males, particularly those less than 50 years old. Therefore, it is probable that inflammation following H. pylori infection contributes to the early stage of atherosclerosis in younger males. Further prospective studies are needed to clarify the relationship between H. pylori infection and atherosclerotic diseases. Because H. pylori infection can be eradicated by a short course of combination antibiotic therapy, studies will be needed to determine whether its eradication reduces the incidence of atherosclerotic diseases.
